Breakthrough in Interstitial Lung Disease Diagnosis: New AI-Driven System

Strategic Insights -

A revolutionary AI-powered system, developed by Michael Muelly and Joshua Reicher, has been patented for the diagnosis of interstitial lung disease, including idiopathic pulmonary fibrosis (IPF), an orphan disease affecting millions worldwide. The system leverages machine learning models to analyze computed tomography (CT) images and clinical data, providing a more accurate and efficient diagnosis.

Key Takeaways:

  • The patented system uses a three-dimensional deep learning model to train on a dataset of CT images and clinical factors, such as pulmonary function tests and surgical biopsy results.
  • The system can accurately diagnose IPF and other interstitial lung diseases, reducing the risk of misdiagnosis and improving patient outcomes.
  • The AI-driven diagnosis process involves extracting image data from CT scans, extracting clinical data, selecting relevant data, normalizing the data, and converting it into a mathematical representation for processing by a machine learning model.
  • The system can also optimize the machine learning model using techniques such as weighted focal loss and stochastic gradient descent with momentum.
  • The target medical condition includes interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF), with a focus on improving diagnostic accuracy and patient outcomes.
  • The claimed methods and systems can be used for automated diagnosis of disease database entities, reducing the need for invasive procedures and improving patient care.

Statistics:

  • The prevalence of ILD ranges from 26.1 to 80.9 per 100,000 people, while the prevalence of IPF ranges from 7.4 to 20.2 per 100,000 people.
  • The average life expectancy for a person with IPF is less than five years, and in many cases, it is less than two years.
  • The patented system has the potential to improve diagnostic accuracy and reduce the risk of misdiagnosis, which can lead to improved treatment outcomes and patient survival.

Sources:

  • Muelly, Michael. Machine learning models for automated diagnosis of disease database entities. U.S. Patent Number 12354749, filed July 12, 2022, and published online on July 8, 2025.
  • NewsRx LLC. Revolutionary AI-Powered System for Interstitial Lung Disease Diagnosis Patented. NewsRx, 2025.